PTC Therapeutics, Huntington's Disease and Fast Track
PTC Therapeutics' Huntington's Treatment Gets FDA Fast Track Designation
PTC Therapeutics' treatment for Huntington's disease has received a fast track designation from U.S. health regulators. The biopharmaceutical company said Thursday that the Food and Drug Administration granted the designation to the PTC518 program which aims to reduce the production of mutated Huntington protein.
FDA Grants Fast Track Designation to PTC518 Huntington's Disease Program
PTC Therapeutics (NASDAQ: PTCT) announced today that the FDA has granted Fast Track designation to the PTC518 program for the treatment of Huntington's disease. Fast Track designation is awarded to promising therapies for diseases of high unmet need.
Potential Tropical Cyclone 9 could become a landfalling major hurricane for the Florida Gulf Coast on Thursday.
With the 11 a.m. advisory, the National Hurricane Center has designated Potential Tropical Cyclone Nine in the Caribbean.
Potential Tropical Cyclone 9 has formed in the Caribbean, and is forecast to continue organizing into a tropical storm and ...
BOSTON, Aug. 27, 2024 /PRNewswire/ -- PTC (Nasdaq: PTC) today announced that it will participate in the following conferences. What: Citi's 2024 Global TMT Conference When: Wednesday, September 4 ...
We have no weather worries in the short term, but the forecast is looking more active for the middle and end of the week as ...
Purchasing an iPhone has never been easier, thanks to Blinkit, a quick commerce platform that has launched its lightning-fast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback